KYV-101
KYV101-004
Phase 3 small_molecule active
Quick answer
KYV-101 for Lupus Nephritis, Systemic Sclerosis, Myasthenia Gravis, Rheumatoid Arthritis, Stiff Person Syndrome is a Phase 3 program (small_molecule) at Kyverna Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kyverna Therapeutics
- Indication
- Lupus Nephritis, Systemic Sclerosis, Myasthenia Gravis, Rheumatoid Arthritis, Stiff Person Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active